SCHEMBL4371335

SCHEMBL4371335

NC1(Cl)N=CC=C(Cl)N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1271231 0.77
SCHEMBL10853339 0.70
SCHEMBL30629321 0.68
SCHEMBL5024965 0.64
SCHEMBL7147350 0.64
SCHEMBL9162828 0.57
SCHEMBL7174682 0.57
SCHEMBL10741690 0.55
SCHEMBL18525220 0.51
SCHEMBL8865294 0.48 HSP90AA1 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114014815-B Preparation method of environment-friendly 4-amino-2, 6-dimethoxy pyrimidine 浙江科技学院 2023-05-30 CN disclosed
CN-110981816-B Synthesis method of 4-amino-2, 6-dimethoxypyrimidine 天和药业股份有限公司 2022-07-05 CN disclosed
CN-114014815-A Preparation method of environment-friendly 4-amino-2, 6-dimethoxypyrimidine 浙江科技学院 2022-02-08 CN disclosed
CN-110981816-A Synthesis method of 4-amino-2, 6-dimethoxypyrimidine 扬州天和药业有限公司 2020-04-10 CN disclosed
US-20090215777-A1 Pyrimidine Derivatives As HSP90 Inhibitors ASTEX THERAPEUTICS LTD. (GB) 2009-08-27 US disclosed